Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Prażmo, , Aniela,
DOB: 08-FEB-1941 (Age: 84)
Gender: female
Address:
pl. Kołłątaja 62/43
97-200 Tomaszów Mazowiecki (Poland)
ID: 9657-869171-7 (ECI)
Report
Date: 23-MAY-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Poradnia rehabilitacyjna
97-200 Tomaszów Mazowiecki (Poland)
Specimen
Collected: 23-MAY-2020

Hematology

Test 23-MAY-2020 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 6.0 4 - 11 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.1 3.8 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.7 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 44.3 38 - 56 %
MCV [Entitic volume] by Automated count 87.6 78 - 98 fL
MCH [Entitic mass] by Automated count 31.7 27 - 34 pg
MCHC [Mass/volume] by Automated count 35.2 H 32 - 35 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 39.8 36 - 55 fL
Platelets [#/volume] in Blood by Automated count 435.2 H 157 - 415 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 245.0 H 13.4 - 17.4 fL
Platelet mean volume [Entitic volume] in Blood by Automated count 9.6 7.4 - 12 fL

Chemistry

Test 23-MAY-2020 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 268.3 H 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 141.6 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 185.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 54.8 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total and LDL cholesterol, indicating increased cardiovascular risk. Platelet count and platelet distribution width are also elevated, which may suggest reactive thrombocytosis or underlying inflammation but should be correlated clinically. Other hematological parameters are within normal limits. Lipid management and further evaluation of platelet abnormalities are recommended.